AOWM
CDMO

Alpha Omega Wealth Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Alpha Omega Wealth Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5
Closed – – 572
2019
Q2 		$0 Buy
+5
New +$21 ﹤0.01% 650

Other funds holding CDMO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alpha Omega Wealth Management's CDMO Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2019, closing a stake of 5 shares.

Alpha Omega Wealth Management first reported a position in CDMO in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 99 funds tracked by Wall St. Rank hold CDMO as of Q3 2019.

  • Alpha Omega Wealth Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Alpha Omega Wealth Management sold 5 Avid Bioservices, Inc. Common Stock shares in Q3 2019.
  • Alpha Omega Wealth Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Alpha Omega Wealth Management's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q2 2019.
  • 99 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.